Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Thursday that its fourth quarter revenues rose 21 percent year over year, in line with preliminary Q4 revenues reported in January.

For the three months ended Dec. 31, 2018, the company reported revenues of $19.4 million, up from $16.0 million in Q4 2017, and beating the analysts' consensus estimate of $19.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.